(EYPT) Eyepoint Pharmaceuticals BollingerBands charts technical analysis
(EYPT) Eyepoint Pharmaceuticals BollingerBands charts technical analysis BollingerBands analysis of Eyepoint Pharmaceuticals | Buy/Sell Eyepoint Pharmaceuticals
Eyepoint Pharmaceuticals trades in USA in Capital Goods sector.
10 day averaged volume of Eyepoint Pharmaceuticals is 2086080
Date | Closing Price | Open | High | Low | Volume |
08 Wed May 2024 | 11.56 | 11.87 | 12.30 | 11.38 | 1.435 Mn |
07 Tue May 2024 | 11.87 | 11.20 | 11.89 | 10.65 | 2.516 Mn |
06 Mon May 2024 | 11.20 | 13.89 | 14.00 | 11.06 | 9.652 Mn |
03 Fri May 2024 | 19.74 | 20.30 | 21.26 | 19.71 | 0.929 Mn |
02 Thu May 2024 | 19.94 | 18.48 | 20.32 | 17.83 | 2.112 Mn |
01 Wed May 2024 | 18.04 | 17.72 | 18.81 | 17.43 | 0.728 Mn |
30 Tue Apr 2024 | 17.60 | 17.42 | 18.04 | 16.94 | 0.957 Mn |
29 Mon Apr 2024 | 17.63 | 16.67 | 17.93 | 16.36 | 0.793 Mn |
26 Fri Apr 2024 | 16.75 | 16.08 | 16.76 | 15.65 | 1.244 Mn |
25 Thu Apr 2024 | 16.16 | 16.26 | 16.26 | 15.51 | 0.75 Mn |
Indicators analysis of Eyepoint Pharmaceuticals (EYPT)
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Eyepoint Pharmaceuticals in short term and the sell signal is strong.
Eyepoint Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.82 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
BollingerBands charts
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Eyepoint Pharmaceuticals in short term and the sell signal is strong.
Eyepoint Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.82 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.